Kornitzer Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Kornitzer Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-395,660	Closed	-$29.8M	–	477
2015 Q2	$29.8M	Sell	395,660 -134,975	-25%	-$7.23M	0.4%	91
2015 Q1	$26.6M	Sell	530,635 -1,810	-0.3%	-$76K	0.32%	107
2014 Q4	$18.5M	Sell	532,445 -26,630	-5%	-$929K	0.22%	131
2014 Q3	$18.3M	Buy	559,075 +474,020	+557%	+$16.7M	0.21%	131
2014 Q2	$3.26M	Buy	+85,055	New	+$2.97M	0.04%	291

Other funds holding KYTH

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Kornitzer Capital Management's KYTH Position: Q3 2015 in Review

Kornitzer Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 395,660 shares — an estimated $29.8M sold.

Kornitzer Capital Management first reported a position in KYTH in Q2 2014 and held it in 5 quarters. The position peaked at $29.8M in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

Kornitzer Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
Kornitzer Capital Management sold 395,660 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $29.8M.
Kornitzer Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 5 quarters.
Kornitzer Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $29.8M in Q2 2015.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Kornitzer Capital Management's 13F filing for Q3 2015, filed 29 Oct 2015.